Eiffel Biotech © All rights reserved

See Our Insight!

Leave your comments to help us become better!

A possible solution for blood clot caused by COVID-19: BSNK66® Nattokinase

photo-1584483766114-2cea6facdf57

This article will introduce you to how Nattokinase solves the problem of blood clots caused by COVID-19.

COVID-19 has ravaged the world for nearly two years. And the epidemic situation in various countries and regions around the world has a tendency to make a comeback. Various variants of viruses are emerging one after another. India, Vietnam, Taiwan, etc. have recently experienced another wave of infection peaks.

In addition to the impact on our respiratory system, doctors and researchers discovered that COVID-19 will have other effects: blood clots. We should not underestimate the problem of thrombosis. Under normal circumstances, thrombosis is closely related to other diseases such as stroke, pulmonary embolism, and cerebral infarction.

A doctor in Los Angeles in the United States had a patient who needed to amputate his leg because of a blood clot caused by COVID-19. Of course, this is not a single case. Although the incidence of thrombosis as a complication is not the highest, we should still pay attention.

Scientists are still exploring the relationship between COVID-19 and thrombosis. But as far as the current situation is concerned, scientists and doctors already have some opinions.

 

Why COVID-19 is related to blood clots?

why COVID-19 causes blood clots First of all, we need to know when the body will produce blood clots. The specific blood cells of platelets and different coagulation factors in the blood can heal broken blood vessels and control bleeding after aggregation. When some clotting factors are missing or damaged and thrombosis is formed, this leads to obstacles in the clotting process, causing these clots to prevent normal blood flow and cause serious problems.

COVID-19 causes inflammation in the body, which triggers the blood clotting system. For example, under normal circumstances. If our skin is broken, the immune system stimulates the blood coagulation system to respond to the wound. Simply put, the signal the body receives is: if I see an infection, I need to react with blood clotting. But when COVID-19, a virus that can infect all parts of the body, invades the body, the body will react more strongly, causing multiple triggers of the coagulation system.

In addition, due to illness, we need to stay in bed and move less, which increases the possibility of increased blood clots.

Thrombosis caused by COVID-19 appears very fast. If you have a history of cardiovascular disease, overweight, or thrombosis, you should pay more attention.

 

Thrombosis and the COVID-19 vaccine

Rolf Marschalek's research of covid-19 vaccinesAccording to current research and reports, both AstraZeneca and Johnson & Johnson vaccines may trigger adverse thrombotic reactions. Although the overall incidence is not high, it should still attract our attention.

Rolf Marschalek, a professor at Goethe University in Frankfurt, Germany, has been studying the thrombotic reaction caused by vaccines since March. His study shows that the cause of thrombosis is the “adenovirus vector”, which is used to deliver the new coronavirus (SARS-CoV-2) to the human body. Genetic instructions for a spiny protein. Studies have shown that this method means that the vaccine is to deliver the DNA gene sequence of the spike protein to the nucleus, rather than the place where the virus normally makes the protein, which is the cytoplasmic fluid inside the cell. Therefore, when the viral spike protein DNA enters the nucleus for transcription, it will trigger partial fragments of the spike protein to split, produce mutations, and fail to bind to the cell membrane that can induce an important immune response.

And because the vaccines of Pfizer, BNT, and Moderna transmit the spinosin gene material into the cell fluid instead of the nucleus, there is no thrombosis problem.

 

COVID-19 Thrombosis High-Risk Group and Symptoms

patients having a history of thrombosis are high-risk groups of covid-19 blood clots

People who have a history of thrombosis (including a history of cardiovascular disease, obesity, atherosclerosis, etc.) are high-risk groups. Patients with severe COVID-19 need to be more careful. If they have not gone to the hospital for treatment but have the following symptoms, they need to seek medical treatment in time:

  • Weakness of hands and feet
  • Speech difficulties
  • Uncontrollable facial expressions
  • Pain, swelling, and congestion in the hands or feet
  • The sudden shortage of breathing
  • Chest pain or neck, jaw, or back pain from chest pain

 

The reference Nattokinase treatment plan for thrombosis caused by COVID-19

If thrombosis occurs, you need to seek medical treatment in time. The sooner you receive treatment, the higher the probability of cure. Prof Adrian Newland pointed out that 75% of patients can survive with timely treatment.

Can we take precautions in our daily lives? Or use non-drug means to treat blood clots?

Nattokinase may be a solution. We can extract this natural enzyme from natto. Nattokinase has a different mechanism of action from traditional thrombolytic drugs such as warfarin. It can break down blood clots by directly hydrolyzing fibrin and plasmin substrates, transform endogenous prourokinase into urokinase (uPA), degrade PAI-1 (plasminogen promoter inhibitor 1), and increase Tissue plasminogen promoter (t-PA) that supports the fibrinolytic activity.

This method of dissolving blood clots through natural foods has been known in Japan for many years. In addition to dissolving thrombus, nattokinase can also lower blood pressure, anti-atherosclerosis, anti-coagulation, and so on.

Nattokinase ingredient logo

Eiffel Biotech is a professional nattokinase manufacturer in Taiwan. We have been researching and manufacturing nattokinase for more than 10 years. We have been working for ten years and cooperated with many universities at home and abroad to develop a unique BSNK66® nattokinase raw material. It has the characteristics of no peculiar natto smell, a wide range of activity, numerous health effects, and high adaptability.

We have various certificates and can quickly meet export requirements. Welcome to contact us directly for more product information!

Leave a Reply